CN102841210A - Retinol detection kit and preparation method thereof - Google Patents
Retinol detection kit and preparation method thereof Download PDFInfo
- Publication number
- CN102841210A CN102841210A CN201210312846XA CN201210312846A CN102841210A CN 102841210 A CN102841210 A CN 102841210A CN 201210312846X A CN201210312846X A CN 201210312846XA CN 201210312846 A CN201210312846 A CN 201210312846A CN 102841210 A CN102841210 A CN 102841210A
- Authority
- CN
- China
- Prior art keywords
- reagent
- 5mmol
- mmol
- damping fluid
- 220mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a detection kit for a retinol binding protein. The interior of a detection kit body comprises reagents R1 and reagents R2, wherein the reagents R1 comprise a buffer solution, polyethylene glycol, sodium azide, sodium ethylene diamine tetracetate and bovine serum albumin; and the reagents R2 comprise a buffer solution, latex grains combined with retinol binding protein monoclonal antibodies, tween-20, sodium azide, sodium ethylene diamine tetracetate and bovine serum albumin. A sample and the reagents are mixed at a certain volume ratio and generate a series of reactions, and then a reactant is placed under a semi/full-automatic biochemical analyzer, and the speed of absorbance change in the position of a main wavelength of 340nm is detected, so that the concentration magnitude of the retinol binding protein is measured and calculated. The detection kit has the advantages of accuracy, stability and convenience.
Description
Technical field
The invention belongs to the biological medicine technology field, relate in particular to a kind of detection kit that detects human retinol-binding protein.
Background technology
RBP ELISA is the combination albumen of specific bond vitamin A in the blood plasma, in the metabolism of vitamin A, plays an important role.
The Clinical detection of RBP ELISA helps the diagnosis of hepatitis, diabetes early diagnosis, kidney trouble.
RBP ELISA is mainly synthetic by the liver rough surfaced endoplasmic reticulum (RER).Be distributed widely in human serum, urine, the cerebrospinal fluid.RBP ELISA exists with composite form in blood.When hepatocellular injury. the synthetic of RBP ELISA is suppressed.Because the half life period of RBP ELISA is 3~12 hours.Its relative molecular weight is little, and relevant with serum total bilirubin, albumin, prothrombin time.So it can reflect the change of liver function sensitively.While acute viral hepatitis patients serum's RBP ELISA content and AST, ALP, ALT negative correlation.So can explain that it is the impaired sensitive index of reflection liver cell that serum retinol combines albumen.
Retinal binding protein is a kind of low molecular protein, and can freely filtering also at glomerular filtration membrane, the overwhelming majority be heavily absorbed and kalabolism by kidney proximal tubule.Under the normal condition, retinal binding protein excretion amount is very little, and when kidney proximal tubule was impaired, retinal binding protein excretion amount obviously increased.Therefore measure the function situation that the retinal binding protein level can reflect renal tubule more delicately, and specificity is higher.
RBP ELISA itself has good stability; Content in vivo is constant relatively; Generally speaking; The content of RBP ELISA is few in the normal person urine, so there is the scholar to think that its excretion in urine can be used as an impaired sensitive index of renal tubular function, can reflect in early days that the infringement of renal tubule asks.Research shows, when diabetes in early days the glomerulus dysfunction do not take place as yet, has had the function damage of renal tubule.And when the diagnosing diabetes tubular injury, retinal binding protein can be used as more responsive diagnosis index of early diabetic nephropathy.For the diagnosis of early diabetic nephropathy provides foundation.So that the patient obtains diagnosis and treatment timely, improve prognosis, improve life quality.
The RBP ELISA assay method is a lot, comprising: (one) radioimmunoassay (RIA), (two) enzymoimmunoassay (ELISA), (three) latex agglutination test and immunoturbidimetry, (four) fluorescence immunoassay, (five) are dripped golden immunization.These methods have the shortcoming of complex operation, length consuming time, excess waste resource, are inappropriate for routine inspection.
Summary of the invention
The detection kit that the purpose of this invention is to provide a kind of RBP ELISA.This kit can directly apply on the automatic clinical chemistry analyzer, accuracy is strong as a result, reagent stability good, easy to use, be convenient to large-scale promotion.
Another object of the present invention provides the production preparation and the method for application of above-mentioned detection kit.
For realizing above-mentioned purpose, kit provided by the invention consists of:
Reagent R1: damping fluid, polyglycol, Sodium azide, sodium ethylene diamine tetracetate, bovine serum albumin(BSA);
Reagent R2: damping fluid, the latex particle that is combined with the RBP ELISA monoclonal antibody, Tween-20, Sodium azide, sodium ethylene diamine tetracetate, bovine serum albumin(BSA).
It is following that the preparation method of mentioned reagent box provided by the invention and behaviour do step:
(a) prepare reagent in following ratio:
Reagent R1:
Tris damping fluid 200-220mmol/L
Polyglycol 5-10 mmol/L
Sodium azide 1-5 mmol/L
Sodium ethylene diamine tetracetate 1-5mmol/L
Bovine serum albumin(BSA) 1-5mmol/L;
Reagent R2:
Tris damping fluid 200-220mmol/L
Be combined with the latex particle 3.5-5% (v/v) of RBP ELISA monoclonal antibody
Tween-20 1-5mmol/L
Sodium azide 0.5-3 mmol/L
Sodium ethylene diamine tetracetate 1-5mmol/L
Bovine serum albumin(BSA) 1-5mmol/L
(b) reagent is mixed with sample to be tested by a certain percentage, make its complete reaction;
(c) measure the absorbance changing value with half/automatic clinical chemistry analyzer;
(d) calculate the concentration of RBP ELISA in the sample according to the absorbance changing value.
Embodiment
Following embodiment is for the more detailed the present invention of explanation, is confined to this but should not be construed as the present invention.
Embodiment 1:
Kit of the present invention is double reagent for example, wherein:
Reagent R1:
Tris damping fluid 200mmol/L
Polyglycol 8 mmol/L
Sodium azide 5 mmol/L
Sodium ethylene diamine tetracetate 5mmol/L
Bovine serum albumin(BSA) 5mmol/L;
Reagent R2:
Tris damping fluid 200mmol/L
Be combined with the latex particle 5% (v/v) of RBP ELISA monoclonal antibody
Tween-20 5mmol/L
Sodium azide 3 mmol/L
Sodium ethylene diamine tetracetate 5mmol/L
Bovine serum albumin(BSA) 5mmol/L.
Embodiment 2: the kit method of application
1. reagent is prepared, and reagent is liquid double reagent, and uncork i.e. usefulness, wherein:
Reagent R1:
Tris damping fluid 200mmol/L
Polyglycol 8 mmol/L
Sodium azide 5 mmol/L
Sodium ethylene diamine tetracetate 5mmol/L
Bovine serum albumin(BSA) 5mmol/L;
Reagent R2:
Tris damping fluid 200mmol/L
Be combined with the latex particle 5% (v/v) of RBP ELISA monoclonal antibody
Tween-20 5mmol/L
Sodium azide 3 mmol/L
Sodium ethylene diamine tetracetate 5mmol/L
Bovine serum albumin(BSA) 5mmol/L.
2. the full-automatic biochemical instrument parameter is provided with
(a) detected temperatures: 37 ℃
(b) detect wavelength: predominant wavelength is 340nm;
(c) reaction time: 10 minutes, wherein, 5 minutes incubation time, 5 minutes reaction time.
3. detect step (all in automatic clinical chemistry analyzer, accomplishing)
(a) get 200 μ L reagent 1 and 10 μ L serum sample mixings;
(b) with the solution behind the mixing 37 ℃ of incubations 5 minutes, read absorbance A1;
(c) add 50 μ L reagent 2 again, react after 5 minutes, read absorbance A2;
(d) calculate △ A=A2-A1.
4. calculate the concentration of RBP ELISA through △ A.
The advantage that the present invention has:
Accuracy is strong as a result, reagent stability good for this kit, easy to use, be convenient to large-scale promotion.Required detecting instrument (Biochemical Analyzer) generally uses at various big hospital and inspection center.
Claims (7)
1. Retinal-binding protein detection kit, it consists of: reagent R1, reagent R2,
Wherein:
A, reagent R1 comprise: 200-220mmol/L Tris damping fluid, 5-10 mmol/L polyglycol, 1-5 mmol/L Sodium azide, 1-5mmol/L sodium ethylene diamine tetracetate, 1-5mmol/L bovine serum albumin(BSA);
B, reagent R2:200-220mmol/L Tris damping fluid, the latex particle that is combined with the RBP ELISA monoclonal antibody, 1-5mmol/L Tween-20,0.5-3 mmol/L Sodium azide, 1-5mmol/L sodium ethylene diamine tetracetate, 1-5mmol/L bovine serum albumin(BSA).
2. the kit of claim 1; It is characterized in that: the preparation method of the latex particle of the RBP ELISA monoclonal antibody among the reagent R2 is: the RBP ELISA monoclonal antibody of 10.5mg/ml and 10% latex particle (diameter 50-100nm); Join in the 200-220mmol/L Tris damping fluid; Concussion reaction 4 hours
The centrifugal supernatant that goes is diluted to 0.5% with 200-220mmol/L Tris damping fluid again, and adds 0.1-0.3 mmol/L Sodium azide.
3. the preparation of mentioned reagent box and method of operating, key step is:
(a) prepare reagent in following ratio:
Reagent R1:
Tris damping fluid 200-220mmol/L
Polyglycol 5-10 mmol/L
Sodium azide 1-5 mmol/L
Sodium ethylene diamine tetracetate 1-5mmol/L
Bovine serum albumin(BSA) 1-5mmol/L;
Reagent R2:
Tris damping fluid 200-220mmol/L
Be combined with the latex particle 3.5-5% (v/v) of RBP ELISA monoclonal antibody
Tween-20 1-5mmol/L
Sodium azide 0.5-3 mmol/L
Sodium ethylene diamine tetracetate 1-5mmol/L
Bovine serum albumin(BSA) 1-5mmol/L;
(b) reagent is mixed with sample to be tested by a certain percentage, make its complete reaction;
(c) measure the absorbance changing value with half/automatic clinical chemistry analyzer;
(d) calculate the concentration of RBP ELISA in the sample according to the absorbance changing value.
4. the method for claim 3 is characterized in that, sample and ratio of reagents should be controlled at 1:20 between the 1:30.
5. the method for claim 3 is characterized in that, temperature of reaction is 37 (± 1) ℃.
6. the method for claim 3 is characterized in that, the reaction time is 8-12 minute.
7. the method for claim 3 is characterized in that, the wavelength that uses half/automatic clinical chemistry analyzer to detect is 340nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210312846XA CN102841210A (en) | 2012-08-30 | 2012-08-30 | Retinol detection kit and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210312846XA CN102841210A (en) | 2012-08-30 | 2012-08-30 | Retinol detection kit and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102841210A true CN102841210A (en) | 2012-12-26 |
Family
ID=47368761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210312846XA Pending CN102841210A (en) | 2012-08-30 | 2012-08-30 | Retinol detection kit and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102841210A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103134934A (en) * | 2013-02-27 | 2013-06-05 | 宁波美康生物科技股份有限公司 | Kit for simultaneously detecting retinol-binding protein (RBP) in urine sample and serum sample |
CN103525769A (en) * | 2013-10-10 | 2014-01-22 | 深圳市菲鹏生物股份有限公司 | Hybridoma cell capable of secreting anti retinol binding protein monoclonal antibody and application |
CN103698284A (en) * | 2013-09-03 | 2014-04-02 | 柏荣诊断产品(上海)有限公司 | Kit and method for determining Lambda free light chain concentration |
CN106093423A (en) * | 2016-05-31 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | A kind of test kit measuring retinol binding protein and preparation method thereof |
CN106383234A (en) * | 2016-08-31 | 2017-02-08 | 上海科华生物工程股份有限公司 | Coating method for retinol-binding protein detection reagent |
CN106932589A (en) * | 2015-12-30 | 2017-07-07 | 上海复星长征医学科学有限公司 | Determine kit of human serum RBP ELISA content and preparation method thereof |
CN107490696A (en) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | A kind of Retinal-binding protein detection kit and detection method |
CN107656065A (en) * | 2017-03-31 | 2018-02-02 | 迈克生物股份有限公司 | Suppress the RBP ELISA latex enhancing immune of rheumatoid factor interference than turbid reagent |
CN108627652A (en) * | 2018-05-31 | 2018-10-09 | 宁波海壹生物科技有限公司 | It is a kind of to detect based on simple grain diameter and simultaneously the kit of RBP ELISA in serum and urine specimen |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998057171A1 (en) * | 1997-06-13 | 1998-12-17 | Medical Biology Institute | Method of detection of cardiac ischemia using fatty acid binding protein |
CN101833009A (en) * | 2010-04-29 | 2010-09-15 | 浙江康特生物科技有限公司 | Double antibody complex retinol-binding protein assay kit |
CN102128935A (en) * | 2010-11-23 | 2011-07-20 | 中生北控生物科技股份有限公司 | Method for detecting hoptoglobin in serum and detecting kit thereof |
CN102621332A (en) * | 2012-04-06 | 2012-08-01 | 上海蓝怡科技有限公司 | Retinol binding protein assay kit based on latex particle coating |
CN102628867A (en) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | Double antibody latex enhanced retinol binding protein detection kit |
CN102628864A (en) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | Kit for determining heart-type fatty acid binding protein in serum or urine by latex enhanced turbidimetric immunoassay |
-
2012
- 2012-08-30 CN CN201210312846XA patent/CN102841210A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998057171A1 (en) * | 1997-06-13 | 1998-12-17 | Medical Biology Institute | Method of detection of cardiac ischemia using fatty acid binding protein |
CN101833009A (en) * | 2010-04-29 | 2010-09-15 | 浙江康特生物科技有限公司 | Double antibody complex retinol-binding protein assay kit |
CN102128935A (en) * | 2010-11-23 | 2011-07-20 | 中生北控生物科技股份有限公司 | Method for detecting hoptoglobin in serum and detecting kit thereof |
CN102628867A (en) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | Double antibody latex enhanced retinol binding protein detection kit |
CN102628864A (en) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | Kit for determining heart-type fatty acid binding protein in serum or urine by latex enhanced turbidimetric immunoassay |
CN102621332A (en) * | 2012-04-06 | 2012-08-01 | 上海蓝怡科技有限公司 | Retinol binding protein assay kit based on latex particle coating |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103134934A (en) * | 2013-02-27 | 2013-06-05 | 宁波美康生物科技股份有限公司 | Kit for simultaneously detecting retinol-binding protein (RBP) in urine sample and serum sample |
CN103698284A (en) * | 2013-09-03 | 2014-04-02 | 柏荣诊断产品(上海)有限公司 | Kit and method for determining Lambda free light chain concentration |
CN103698284B (en) * | 2013-09-03 | 2015-07-15 | 柏荣诊断产品(上海)有限公司 | Kit and method for determining Lambda free light chain concentration |
CN103525769A (en) * | 2013-10-10 | 2014-01-22 | 深圳市菲鹏生物股份有限公司 | Hybridoma cell capable of secreting anti retinol binding protein monoclonal antibody and application |
CN103525769B (en) * | 2013-10-10 | 2015-11-18 | 菲鹏生物股份有限公司 | Hybridoma and the application of anti-retinol conjugated protein monoclonal antibody can be secreted |
CN106932589A (en) * | 2015-12-30 | 2017-07-07 | 上海复星长征医学科学有限公司 | Determine kit of human serum RBP ELISA content and preparation method thereof |
CN106093423A (en) * | 2016-05-31 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | A kind of test kit measuring retinol binding protein and preparation method thereof |
CN106383234A (en) * | 2016-08-31 | 2017-02-08 | 上海科华生物工程股份有限公司 | Coating method for retinol-binding protein detection reagent |
CN106383234B (en) * | 2016-08-31 | 2017-11-24 | 上海科华生物工程股份有限公司 | The method for coating of Retinal-binding protein detection reagent |
CN107656065A (en) * | 2017-03-31 | 2018-02-02 | 迈克生物股份有限公司 | Suppress the RBP ELISA latex enhancing immune of rheumatoid factor interference than turbid reagent |
CN107656065B (en) * | 2017-03-31 | 2020-06-12 | 迈克生物股份有限公司 | Retinol binding protein latex enhanced immunoturbidimetry reagent for inhibiting rheumatoid factor interference |
CN107490696A (en) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | A kind of Retinal-binding protein detection kit and detection method |
CN108627652A (en) * | 2018-05-31 | 2018-10-09 | 宁波海壹生物科技有限公司 | It is a kind of to detect based on simple grain diameter and simultaneously the kit of RBP ELISA in serum and urine specimen |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102841210A (en) | Retinol detection kit and preparation method thereof | |
CN101452001B (en) | Quantitative determination RBP4 kit by chemiluminescence magnetic enzymoimmune method | |
CN109085333B (en) | Preparation and detection kit for rheumatoid factor antigen and preparation method | |
CN101819207B (en) | Kit for detecting alpha 1-microglobulin by nano microsphere immunonephelometry | |
CN108663525A (en) | A kind of heart infarction heart failure magnetic particle microflow controlled biochip, detection method | |
CN102507918B (en) | Kit for determining anti-cyclic citrullinated peptide (Anti-CCP) antibody | |
CN101377492A (en) | Bladder chalone C determining reagent kit | |
CN102680698A (en) | Neutrophil gelatinase-associated lipocalin (NGAL) assay kit (latex-enhanced immunoturbidimetry) | |
CN102621332A (en) | Retinol binding protein assay kit based on latex particle coating | |
CN103454431A (en) | Immunoturbidimetric kit for detecting beta2-microglobulin and preparation method thereof | |
CN102788881A (en) | Prealbumin detection reagent kit and preparation method thereof | |
CN103575891A (en) | Kit for comprehensively detecting HE4 and CA125 and application of kit | |
CN102353789A (en) | Joint detection method for heart cerebrovascular disease-related protein marker and diagnostic kit thereof | |
CN106324251B (en) | The preparation method and beta 2-microglobulin detecting kit of small fragment BMG antibody | |
CN105486875A (en) | Retinol conjugated protein detection kit | |
CN102749460A (en) | Troponin detection kit and preparing method thereof | |
CN103575902A (en) | Kit for comprehensively detecting four indexes of ovarian cancer through time-resolved fluorescence and application of kit | |
CN102749457A (en) | Beta2-microglobulin detection kit and preparing method thereof | |
CN110988333A (en) | Serum tissue metalloproteinase inhibitor-1 chemiluminescence immunoassay kit and preparation method thereof | |
CN106596968A (en) | Dot gold infiltration kit for detecting urine microalbumin, and application of dot gold infiltration kit | |
CN108627652B (en) | It is a kind of to detect based on simple grain diameter and simultaneously the kit of RBP ELISA in serum and urine specimen | |
CN102749458A (en) | Cystatin C detection kit and preparing method thereof | |
CN102305866B (en) | Detection device for quickly diagnosing acute myocardial infarction | |
CN102818900A (en) | Detection kit for apolipoprotein E and preparation method thereof | |
CN105131105A (en) | Cortisol immunogen, derivative, antibody, detection reagent and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121226 |